steroidinduc
osteonecrosi
femor
head
sonfh
devast
irrevers
disabl
diseas
develop
follow
steroid
therapi
function
hip
joint
markedli
impair
femor
head
collaps
glucocorticoid
gc
therapi
common
caus
onfh
onset
sonfh
within
sever
month
follow
administr
steroid
regardless
continu
steroid
administr
expans
necrot
area
found
recurr
identifi
due
ischemia
patient
symptom
sonfh
occur
pain
note
femor
head
collaps
approxim
patient
use
gc
develop
sonfh
leg
notabl
china
patient
sever
acut
respiratori
syndrom
prescrib
gc
develop
femor
head
osteonecrosi
sonfh
compris
approxim
half
nontraumat
femor
head
necrosi
total
patient
femor
head
osteonecrosi
admit
third
affili
hospit
sun
yatsen
univers
guangzhou
guangdong
china
januari
januari
histori
use
gc
major
young
male
present
patient
sonfh
alreadi
exceed
million
china
howev
pathogenesi
diseas
remain
larg
unknown
prevent
treatment
yet
establish
progress
system
biolog
proteom
approach
provid
valuabl
tool
studi
whole
protein
content
biolog
sampl
one
set
experi
one
reliabl
technolog
twodimension
electrophoresi
differ
gel
electrophoresi
dige
analysi
coupl
mass
spectrometri
identif
technolog
recent
employ
screen
potenti
bioactiv
molecul
underli
pathogenesi
arthriti
osteopenia
report
protein
level
serum
joint
fluid
bone
tissu
correl
sever
rheumatoid
arthriti
autoimmun
respons
ankylos
spondyl
anim
model
loss
cartilag
integr
osteoarthr
estrogen
lossinduc
osteoporosi
howev
chang
detect
serum
protein
profil
patient
sonfh
yet
report
purpos
present
studi
find
potenti
biomark
sonfh
use
proteom
technolog
analyz
serum
protein
profil
patient
sonfh
healthi
control
group
studi
approv
institut
review
board
third
affili
hospit
inform
consent
obtain
patient
total
patient
includ
five
femal
seven
male
fulfil
inclus
exclus
criteria
inclus
criteria
includ
receiv
singl
shortcours
corticosteroid
medic
within
three
year
prior
present
onfh
identifi
typic
magnet
reson
imag
mri
find
stage
ficat
classif
system
previou
treatment
femor
head
exclus
criteria
sampl
histori
evid
metabol
bone
diseas
includ
hyper
hypoparathyroid
paget
diseas
renal
osteodystrophi
presenc
cancer
bone
metastasi
total
healthi
volunt
includ
five
femal
seven
male
enrol
control
group
peripher
venou
blood
ml
drawn
patient
outpati
depart
procedur
room
prior
gener
anesthesia
total
hip
replac
blood
sampl
process
collect
serum
store
analysi
blood
sampl
ml
subject
collect
dri
tube
earli
morn
allow
clot
h
room
temperatur
sampl
centrifug
g
min
supernat
dispens
ml
aliquot
store
use
serum
sampl
process
accord
standard
protocol
sampl
thaw
room
temperatur
high
abund
protein
albumin
immunoglobulin
g
igg
deplet
blue
albumin
igg
deplet
kit
sigmaaldrich
inc
st
loui
mo
usa
per
manufactur
instruct
subsequ
sampl
clean
cleanup
kit
ge
healthcar
piscataway
nj
usa
accord
manufactur
instruct
protein
quantifi
use
quant
kit
ge
healthcar
protein
concentr
sampl
adjust
mgml
verifi
sdspage
coomassi
blue
stain
limit
experiment
variat
ensur
accur
ingel
match
sampl
label
fluoresc
cydy
dige
fluor
minim
dye
label
kit
ge
healthcar
use
tag
follow
manufactur
instruct
cyanin
use
intern
standard
sampl
gener
mix
togeth
aliquot
sampl
patient
control
group
use
label
sampl
control
patient
group
respect
label
reaction
carri
dark
ice
label
sampl
subject
cm
immobil
ph
gradient
ipg
strip
ph
ge
healthcar
first
dimension
isoelectr
focus
subsequ
second
dimension
sdspage
polyacrylamid
gel
run
triplic
sampl
reduc
geltogel
variat
gel
scan
use
typhoon
variabl
mode
imag
ge
healthcar
excitationemiss
wavelength
specif
cydy
immedi
subsequ
scan
gel
stain
deep
purpl
store
subsequ
mass
spectrometr
identif
imag
process
decyd
differenti
gel
analysi
softwar
ge
healthcar
identifi
chang
spot
fluoresc
intens
protein
consid
differenti
express
abund
show
chang
patient
control
group
p
use
oneway
analysi
varianc
dispar
point
excis
use
ettan
spot
hand
workstat
ge
healthcar
destain
subject
ingel
trypsin
digest
peptid
extract
subsequ
mass
spectrometri
follow
trypsin
digest
protein
identif
carri
ettan
malditof
mass
spectromet
ge
healthcar
trypsin
autodigest
peak
mz
da
use
intern
calibr
spectrum
correspond
sum
acquisit
eight
laser
puls
threshold
signalnois
exceed
set
valu
result
data
analyz
mascot
search
engin
matrix
scienc
london
uk
protein
identif
compar
nation
center
biotechnolog
inform
swissprot
protein
databas
follow
keyword
use
search
trypsin
digest
homo
sapien
kda
protein
mass
ppm
peptid
toler
serum
protein
sampl
prepar
describ
dilut
laemmli
buffer
resolv
sdspage
invitrogen
life
technolog
carlsbad
ca
usa
separ
protein
transfer
polyvinyliden
fluorid
membran
block
skim
dri
milk
trisbuff
salin
contain
tween
tbst
h
room
temperatur
incub
antibodi
overnight
subsequ
wash
two
time
tbst
membran
incub
correspond
horseradish
peroxidaseconjug
secondari
antibodi
h
room
temperatur
protein
band
detect
use
ecl
plu
forevergen
bioscienc
co
ltd
guangzhou
china
imag
acquir
imag
system
gel
doc
xr
system
biorad
hercul
ca
usa
elisa
assay
use
microtit
plate
assay
perform
individu
sampl
group
chosen
randomli
match
across
group
primari
secondari
antibodi
obtain
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
standard
curv
gener
fourparamet
curvefit
use
softmaxpro
v
softwar
molecular
devic
corp
sunnyval
ca
usa
data
analys
perform
spss
spss
inc
chicago
il
usa
statist
signific
differ
determin
use
student
ttest
tukey
method
perform
correct
multipl
comparison
valu
report
mean
standard
deviat
p
consid
indic
statist
signific
differ
total
patient
sonfh
age
year
rang
year
healthi
volunt
age
year
rang
year
enrol
signific
differ
age
sonfh
healthi
volunt
group
patient
diagnos
onfh
mri
patient
classifi
stage
ficat
classif
system
enrol
studi
medic
record
show
receiv
glucocorticoid
therapi
due
arthralgia
mean
steroid
dose
equival
milligram
prednison
mg
rang
mg
mean
time
administr
steroid
develop
hip
symptom
month
rang
month
none
fulfil
diagnosi
criteria
rheumatoid
arthriti
dige
perform
analyz
differenti
protein
express
previous
describ
approxim
protein
spot
detect
across
four
gel
decyd
imag
analysi
softwar
ge
healthcar
fig
show
superimpos
imag
pseudocolor
sera
sampl
posit
spot
correspond
protein
reveal
dige
analysi
fig
present
differ
protein
express
decyd
spot
simul
four
protein
spot
decreas
abund
patient
control
group
identifi
computerassist
compar
analysi
p
student
ttest
tabl
confirm
chang
four
protein
spot
two
prepar
gel
load
protein
extract
run
parallel
follow
deep
purpl
stain
decreas
protein
abund
consist
result
cydy
label
imag
analyz
decyd
softwar
four
protein
reveal
downregul
sera
patient
sonfh
four
differenti
protein
spot
excis
digest
trypsin
gel
malditof
peptid
mass
fingerprint
pmf
analysi
product
spectra
gener
malditofmsm
search
swissprot
databas
exact
match
use
mascot
pmf
fig
four
protein
respect
inhibitor
heavi
chain
complement
compon
tabl
valid
differenti
express
four
protein
eight
serum
sampl
use
dige
experi
assess
western
blot
analysi
specif
antibodi
level
significantli
lower
patient
group
control
group
fig
consist
result
proteom
studi
subsequ
determin
whether
protein
express
differenti
femor
head
tissu
necrosi
test
case
protein
prepar
necrot
femor
head
tissu
analyz
elisa
express
significantli
lower
patient
group
control
group
fig
consist
result
serum
sampl
chang
observ
level
necrot
bone
tissu
data
shown
incid
sonfh
increas
year
year
diagnosi
disord
still
reli
imag
examin
often
fail
detect
lesion
earli
stage
therefor
number
patient
miss
opportun
earli
treatment
import
find
diagnost
biomark
sonfh
sinc
blood
test
commonli
use
clinic
practic
protein
profil
serum
patient
sonfh
healthi
volunt
analyz
use
cuttingedg
proteom
technolog
aim
identifi
protein
whose
level
blood
significantli
alter
patient
sonfh
ensur
reproduc
accuraci
object
experi
follow
step
implement
minim
experiment
error
sampl
first
sampl
select
criteria
strictli
follow
secondli
high
abund
protein
remov
prior
electrophoresi
otherwis
would
mask
low
abund
protein
fluoresc
label
dige
employ
intern
standard
use
protein
spot
dige
softwar
design
dige
automat
correct
protein
amount
accord
intern
standard
thu
approach
significantli
improv
reproduc
sensit
present
studi
four
protein
show
lower
express
serum
patient
sonfh
normal
subject
chang
confirm
western
blot
express
protein
also
examin
necrot
bone
tissu
unlik
serum
necrot
bone
tissu
detect
amount
addit
show
differ
abund
two
group
downregul
protein
level
necrot
bone
tissu
consist
result
serum
pathogenesi
sonfh
remain
unclear
sever
mechan
propos
includ
lipid
metabol
dysfunct
intravascular
coagul
apoptosi
reactiv
oxygen
imbal
present
studi
show
express
significantli
alter
patient
sonfh
four
protein
close
associ
apoptosi
therefor
present
studi
support
apoptosi
play
major
role
sonfh
degrad
product
cytokin
acut
phase
reactiv
protein
produc
macrophag
hepatocyt
key
factor
activ
complement
system
activ
complement
cascad
caus
varieti
biolog
effect
includ
immun
respons
gener
sensit
lymphocyt
alter
metabol
blood
sugar
lipid
howev
limit
studi
systemat
elucid
mechan
immun
system
affect
sonfh
wu
et
al
show
complement
factor
precursor
elev
serum
patient
onfh
previou
studi
show
complement
factor
precursor
play
import
role
homeostasi
inflamm
necrosi
apoptosi
onfh
present
result
show
complement
activ
reduc
patient
sonfh
may
attribut
immunosuppress
effect
steroid
excess
steroid
suppress
complement
activ
immun
complex
format
familian
et
al
found
plasma
level
increas
major
patient
rheumatoid
arthriti
prior
therapi
significantli
decreas
follow
start
infliximab
immunosuppress
agent
treatment
mechan
complement
inhibit
involv
sonfh
requir
studi
translat
secret
blood
cleav
plasma
kallikrein
two
smaller
form
mrna
specif
express
liver
gene
part
cluster
similar
gene
chromosom
two
transcript
variant
encod
differ
isoform
found
also
acut
phase
reactiv
protein
biolog
function
remain
unknown
detect
swine
bovin
rat
model
experimentallyinduc
acut
inflamm
pineiro
et
al
show
human
mrna
secret
protein
highli
upregul
hepatoma
cell
bost
et
al
assum
may
interact
compon
extracellular
matrix
modul
cell
migrat
prolifer
develop
acutephas
respons
clear
onfh
accompani
inflamm
asept
inflamm
present
patient
onfh
conceiv
persist
consumpt
inflamm
effect
steroid
lead
decreas
serum
studi
necessari
address
role
diseas
inhibitor
matrix
metalloproteas
mmp
mainli
synthes
hepatocyt
liver
small
amount
also
produc
number
cell
includ
lung
fibroblast
macrophag
astrocyt
tumor
cell
function
broad
irrevers
proteinas
inhibitor
involv
variou
physiolog
process
regul
sever
key
factor
sonfh
conform
chang
activ
result
exposur
bind
site
cell
surfac
receptor
includ
lowdens
lipoprotein
receptorrel
protein
upon
bind
complex
extracellular
matrix
rapidli
remov
block
lipid
catabol
modul
blood
coagul
report
simpson
et
al
significantli
enhanc
plasmin
gener
howev
bind
vascular
endotheli
growth
factor
result
inhibit
heparin
activ
lead
elev
coagul
human
verifi
effect
decreas
releas
superoxid
radic
polynuclear
leukocyt
follow
radiat
activ
superoxid
dismutas
red
cell
also
increas
free
radic
mmp
imbal
exist
patholog
process
sonfh
kerachian
et
al
demonstr
gene
significantli
upregul
avascular
necrosi
rat
femor
head
induc
steroid
along
find
present
studi
show
significantli
lower
bone
tissu
patient
sonfh
lower
may
affect
process
sonfh
aspect
consist
bone
tissu
serum
level
also
decreas
conclus
involv
multipl
mechan
underli
sonfh
includ
blood
coagul
hyperlipidemia
free
radic
mmp
degrad
underscor
critic
role
develop
sonfh
therefor
may
becom
novel
potenti
biomark
novel
therapeut
target
sonfh
